A preclinical study evaluating AAVrh10-based gene therapy for sanfilippo syndrome

Leanne K. Winner, Helen Beard, Sofia Hassiotis, Adeline A. Lau, Amanda J. Luck, John J. Hopwood, Kim M. Hemsley

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)

Abstract

Mucopolysaccharidosis type IIIA (MPS IIIA) is predominantly a disorder of the central nervous system, caused by a deficiency of sulfamidase (SGSH) with subsequent storage of heparan sulfate-derived oligosaccharides. No widely available therapy exists, and for this reason, a mouse model has been utilized to carry out a preclinical assessment of the benefit of intraparenchymal administration of a gene vector (AAVrh10-SGSH-IRES-SUMF1) into presymptomatic MPS IIIA mice. The outcome has been assessed with time, measuring primary and secondary storage material, neuroinflammation, and intracellular inclusions, all of which appear as the disease progresses. The vector resulted in predominantly ipsilateral distribution of SGSH, with substantially less detected in the contralateral hemisphere. Vector-derived SGSH enzyme improved heparan sulfate catabolism, reduced microglial activation, and, after a time delay, ameliorated GM3 ganglioside accumulation and halted ubiquitin-positive lesion formation in regions local to, or connected by projections to, the injection site. Improvements were not observed in regions of the brain distant from, or lacking connections with, the injection site. Intraparenchymal gene vector administration therefore has therapeutic potential provided that multiple brain regions are targeted with vector, in order to achieve widespread enzyme distribution and correction of disease pathology.

Original languageEnglish
Pages (from-to)363-375
Number of pages13
JournalHUMAN GENE THERAPY
Volume27
Issue number5
DOIs
Publication statusPublished - 1 May 2016
Externally publishedYes

Fingerprint Dive into the research topics of 'A preclinical study evaluating AAVrh10-based gene therapy for sanfilippo syndrome'. Together they form a unique fingerprint.

Cite this